REVO BIOLOGICS, INC – Trademark Portfolio

Entity Type: 03

REVO BIOLOGICS, INC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ATRYN ANTITHROMBIN (RECOMBINANT). The owner is based in FRAMINGHAM, MA.

175 CROSSING BLVD

FRAMINGHAM, MA 01702

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

REVO BIOLOGICS, INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

40
Treatment & Processing (2 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does REVO BIOLOGICS, INC have?

REVO BIOLOGICS, INC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 cancelled.

What trademark classes does REVO BIOLOGICS, INC file in?

REVO BIOLOGICS, INC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are REVO BIOLOGICS, INC's most well-known trademarks?

REVO BIOLOGICS, INC's registered trademark portfolio includes well-known marks such as ATRYN ANTITHROMBIN (RECOMBINANT). These are among 1 currently registered trademark in the portfolio.

What is REVO BIOLOGICS, INC's trademark registration success rate?

REVO BIOLOGICS, INC has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.